IRCT20180825040860N1招募中3 期
The efficacy of Eplerenon drug in patient with Acute CSCR (Central SerousChorioretinopathy)
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •Acute onset of disease (less than 3 months)
- •without history of previous treatments including treatment with drugs, PDT, Photocuagulation LASER
- •absence of any pathology and impaired vision in other eye
- •absence of ophthalmic eye pathology such as Glaucoma, Retinal disease and uveitis
- •not taking corticostroids agents
- •normal kidney lab tests for treatment group
- •having consent to participating in study
排除标准
- •does not having Consent to participating in study
- •Younger than 18 years old
- •suffering from any ocular or kidney disease
研究者
相似试验
招募中
1 期
Evaluation of the effect of Eplerenone in Central serous chorioretinopathy )CSCRCentral serous chorioretinopathyIRCT20220122053792N1Oroumia University of Medical Sciences34
已完成
不适用
Investigation of an efficacy of eplerenone combined therapy for hypertensive patients with chronic kidney disease that enough hypotensive effect are not obtained with an angiotensin receptor blockerHypertensive patients with chronic kidney disease that enough hypotensive effect is not obtained with an angiotensin receptor blockerJPRN-UMIN000005956OWASE study Project Office200
招募中
4 期
Comparative study of eplerenone-based treatment strategy versus irbesartan-based blood pressure lowering in obese hypertensive patients (HEBRO Study)Hypertension2024-519749-31-00Institute For Study Research Education And Therapy Of Vascular Heart Brain And Kidney Nosologies198
进行中（未招募）
1 期
REMODEL-AMIEUCTR2014-005407-24-CZIKEM
招募中
3 期
Evaluation of the effect of oral eplerenone in the management of Acute Central Serous ChorioretinopathyAcute Central Serous Chorioretinopathy.Separation of retinal layersH35.7IRCT20220423054621N1Bagheiat-allah University of Medical Sciences20